IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8680100 B1

PDFFull Text
Date of Patent:
Mar. 25, 2014

Filed:

Dec. 01, 2009

Sulfonylhydrazide compounds for treating proliferative disorders

Applicants:

Jun Jiang, Norwood, MA (US);

Teresa Kowalczyk-przewloka, Tewksbury, MA (US);

Stefan M. Schweizer, Memphis, TN (US);

Zhi-qiang Xia, Acton, MA (US);

Shoujun Chen, Bedford, MA (US);

Christopher Borella, Bedford, MA (US);

Lijun Sun, Harvard, MA (US);

Inventors:

Jun Jiang, Norwood, MA (US);

Teresa Kowalczyk-Przewloka, Tewksbury, MA (US);

Stefan M. Schweizer, Memphis, TN (US);

Zhi-Qiang Xia, Acton, MA (US);

Shoujun Chen, Bedford, MA (US);

Christopher Borella, Bedford, MA (US);

Lijun Sun, Harvard, MA (US);

Assignee:

Synta Pharmaceuticals Corp., Lexington, MA (US);

Attorneys:

McCarter & English, LLP

Steven G. Davis

Primary Examiner:

Alicia L Otton

Assistant Examiner:

Amanda L Aguirre

Int. Cl.
CPC ...
A61K 31/5375 (2006.01); A61K 31/4965 (2006.01); A61K 31/445 (2006.01); A61K 31/4409 (2006.01); A61K 31/426 (2006.01); A61K 31/421 (2006.01); A61K 31/402 (2006.01); A61K 31/381 (2006.01); A61K 31/357 (2006.01); A61K 31/341 (2006.01); A61K 31/27 (2006.01); A61K 31/16 (2006.01); C07D 295/215 (2006.01); C07D 241/28 (2006.01); C07D 211/98 (2006.01); C07D 213/78 (2006.01); C07D 277/56 (2006.01); C07D 263/34 (2006.01); C07D 207/12 (2006.01); C07D 333/68 (2006.01); C07D 317/46 (2006.01); C07D 307/68 (2006.01); C07C 333/12 (2006.01); C07C 327/18 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention is directed to compounds represented by structural formula (I), or a pharmaceutically acceptable salt or a transition metal chelate, coordinate or complex thereof or a transition metal chelate, coordinate or complex of a deprotonated form of the compound. Pharmaceutical composition and method of use for these compounds are also included.

Find Patent Forward Citations

Loading…